World Association of Sarcoidosis and Other Granulomatous Disorders, 2026
Natural Asp-tRNA Synthetase Fragment Interacts with LTBP-1 on the ECM Promoting Myofibroblast Apoptosis and Reducing Fibrosis
Extracellular Matrix Pharmacology Congress, 2026
A Bispecific Antibody Designed to Act as a NRP2/PLXNA1 Agonist Mimics Anticancer Activity of SEMA3F
Journal of Biological Chemistry (2025)
Subcutaneous Delivery of a Natural Asp-tRNA Synthetase Fragment Targeting Myofibroblasts Shows Strong Exposure and Reduced Markers of Lung Inflammation
Keystone Symposia on Fibrosis: Cross Organ Pathology and Pathways to Clinical Development, 2026
Advancing a Therapeutic Platform Based on tRNA Synthetases for Treatment of Fibrotic Lung Diseases
Federation of European Biochemical Societies: Expanding Frontiers in Aminoacyl-tRNA Synthetase Research, 2025
EFZO-FIT™: The Largest Ever Interventional Trial in Pulmonary Sarcoidosis
European Respiratory Society, 2025
Incidence, Prevalence, and Mortality of Pulmonary Sarcoidosis with Parenchymal Involvement in the US
American Thoracic Society, 2025
EFZO-FIT™, the Largest Placebo-Controlled Trial in Pulmonary Sarcoidosis
American Thoracic Society, 2025
Real-World Treatment Patterns Among Pulmonary Sarcoidosis Patients with Parenchymal Involvement
American Thoracic Society, 2025
ATYR0101: A New Approach to Fibrosis
American Thoracic Society Respiratory Innovation Summit, 2025